Comunicati Stampa
Salute e Benessere

OrbusNeich Launches a High-Capacity Logistics Center in the Netherlands

Commenting on the logistics center opening, Mr. David Chien, Chairman, Executive Director and Chief Executive Officer of OrbusNeich stated, "This investment aligns perfectly with our strategic vision as it enhances and strengthens our integrated supply chain. Following our recent acquisition of eucatech AG, we have enriched our product portfolio with innovative devices such as drug-eluting balloons. This expansion reinforces our commitment to providing superior quality products to customers and brings us closer to them, further solidifying our dedication to serving them."
the Netherlands, (informazione.it - comunicati stampa - salute e benessere)

Commenting on the logistics center opening, stated, "This investment aligns perfectly with our strategic vision as it enhances and strengthens our integrated supply chain. Following our recent acquisition of eucatech AG, we have enriched our product portfolio with innovative devices such as drug-eluting balloons. This expansion reinforces our commitment to providing superior quality products to customers and brings us closer to them, further solidifying our dedication to serving them."

The new setup enhances productivity, raise logistics management efficiency, and redefines storage capabilities. This also significantly increases its export capacity and strengthens the sales and distribution capabilities domestically and abroad. The facility features advanced digital temperature monitoring equipment, supporting both the Group's digitalization initiatives as well as its sustainability goals by enabling more efficient, data-driven environmental management of the warehouse. This aligns with the Group's commitment to digitalization and sustainability as part of OrbusNeich's long-term strategy.

OrbusNeich is a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China , OrbusNeich sells its products in more than 70 countries and regions worldwide. It is also actively expanding into neuro vascular intervention and structural heart disease. As of June 30, 2024 , OrbusNeich has more than 230 granted patents and published patent applications worldwide. Its in-house R&D team has more than two decades of product development experience and has developed world-leading proprietary technologies.

For more information, please visit the Group's official website: https://orbusneich.com/ .

 

View original content: https://www.prnewswire.co.uk/news-releases/orbusneich-launches-a-high-capacity-logistics-center-in-the-netherlands-302258460.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili